# EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE
> **ANDA214053** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2024-05-17
## Drug
- **FDA Application Number:** ANDA214053
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE
- **Generic name:** Emtricitabine
- **Active ingredients:** EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** APOTEX
- **First approval:** 2024-05-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214053)
---
*MORVS · CC0 1.0*